InvestorsHub Logo
Followers 21
Posts 1676
Boards Moderated 0
Alias Born 07/09/2005

Re: None

Monday, 11/30/2020 2:22:34 PM

Monday, November 30, 2020 2:22:34 PM

Post# of 137
11/30/2020
Hookipa Pharma price target raised to $25 from $19 at JMP Securities
HOOK JMP Securities analyst Roy Buchanan raised the firm's price target on Hookipa Pharma to $25 from $19 and keeps an Outperform rating on the shares after the company announced interim results from the Phase 2 trial of HB-101 to vaccinate CMV- transplant patients receiving a CMV+ kidney. The analyst believes that good immune and viremia results for the three-dose group indicate that HB-101 can produce clinical benefit for this important and difficult indication, and provide additional validation of the platform.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HOOK News